These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24251901)

  • 41. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J
    Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Hayes DJ; Mosher TM; Greenshaw AJ
    Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice.
    Kamens HM; Andersen J; Picciotto MR
    Alcohol Clin Exp Res; 2010 Dec; 34(12):2053-60. PubMed ID: 20946306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amphetamine- and nicotine-induced cross-sensitization in adolescent rats persists until adulthood.
    Santos GC; Marin MT; Cruz FC; Delucia R; Planeta CS
    Addict Biol; 2009 Jul; 14(3):270-5. PubMed ID: 19523043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mammalian target of rapamycin pathway in the basolateral amygdala is critical for nicotine-induced behavioural sensitization.
    Gao Y; Peng S; Wen Q; Zheng C; Lin J; Tan Y; Ma Y; Luo Y; Xue Y; Wu P; Ding Z; Lu L; Li Y
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1881-94. PubMed ID: 24916432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
    Turner JR; Castellano LM; Blendy JA
    J Pharmacol Exp Ther; 2010 Aug; 334(2):665-72. PubMed ID: 20435920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
    Rollema H; Hajós M; Seymour PA; Kozak R; Majchrzak MJ; Guanowsky V; Horner WE; Chapin DS; Hoffmann WE; Johnson DE; McLean S; Freeman J; Williams KE
    Biochem Pharmacol; 2009 Oct; 78(7):813-24. PubMed ID: 19501054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine.
    Reichel CM; Murray JE; Barr JD; Bevins RA
    Neuropharmacology; 2010 Jun; 58(8):1237-45. PubMed ID: 20302882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice.
    Ciudad-Roberts A; Camarasa J; Pubill D; Escubedo E
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():201-9. PubMed ID: 23466442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The nicotine + alcohol interoceptive drug state: contribution of the components and effects of varenicline in rats.
    Randall PA; Cannady R; Besheer J
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3061-74. PubMed ID: 27334469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine.
    Jackson A; Silk S; Buhidma Y; Shoaib M
    Addict Biol; 2017 Sep; 22(5):1316-1328. PubMed ID: 27440124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.
    Rudnick ND; Strasser AA; Phillips JM; Jepson C; Patterson F; Frey JM; Turetsky BI; Lerman C; Siegel SJ
    Nicotine Tob Res; 2010 Jun; 12(6):589-97. PubMed ID: 20395358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of varenicline for smoking cessation in bipolar disorder.
    Goldberg JF
    J Clin Psychiatry; 2014 Jul; 75(7):773-4. PubMed ID: 25093473
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein.
    Billen B; Spurny R; Brams M; van Elk R; Valera-Kummer S; Yakel JL; Voets T; Bertrand D; Smit AB; Ulens C
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9173-8. PubMed ID: 22619328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nicotine and varenicline ameliorate changes in reward-based choice strategy and altered decision-making in methamphetamine-treated rats.
    Mizoguchi H; Wang T; Kusaba M; Fukumoto K; Yamada K
    Behav Brain Res; 2019 Feb; 359():935-941. PubMed ID: 29935276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Varenicline for smoking cessation in the bipolar patient.
    Tofler IR
    J Clin Psychiatry; 2015 May; 76(5):625. PubMed ID: 26035192
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of simultaneous exposure to stress and nicotine on nicotine-induced locomotor activation in adolescent and adult rats.
    Zago A; Leão RM; Carneiro-de-Oliveira PE; Marin MT; Cruz FC; Planeta CS
    Braz J Med Biol Res; 2012 Jan; 45(1):33-7. PubMed ID: 22086465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged exposure of rats to varenicline increases anxiety and alters serotonergic system, but has no effect on memory.
    Zaccarelli-Magalhães J; Sandini TM; de Abreu GR; Petrocelli BM; Moreira N; Reis-Silva TM; Lebrun I; Flório JC; Ricci EL; Fukushima AR; Faria Waziry PA; de Souza Spinosa H
    Pharmacol Biochem Behav; 2019 Jun; 181():1-8. PubMed ID: 30946884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.